| Breakdown | Feb 2026 | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 566.26B | 537.68B | 575.66B | 555.96B | 479.08B |
| Gross Profit | 199.75B | 191.48B | 209.10B | 192.01B | 168.65B |
| EBITDA | 69.38B | 103.07B | 86.55B | 83.17B | 70.19B |
| Net Income | 36.81B | 56.99B | 50.69B | 51.78B | 38.35B |
Balance Sheet | |||||
| Total Assets | 814.59B | 743.77B | 702.34B | 653.13B | 559.04B |
| Cash, Cash Equivalents and Short-Term Investments | 61.39B | 63.31B | 44.69B | 46.74B | 57.23B |
| Total Debt | 125.19B | 109.53B | 95.90B | 99.56B | 68.04B |
| Total Liabilities | 319.62B | 304.17B | 294.32B | 298.06B | 260.94B |
| Stockholders Equity | 484.86B | 431.19B | 399.34B | 347.50B | 291.23B |
Cash Flow | |||||
| Free Cash Flow | 6.19B | 19.20B | 23.59B | -24.14B | 25.01B |
| Operating Cash Flow | 54.49B | 56.51B | 54.62B | -2.21B | 49.23B |
| Investing Cash Flow | -46.18B | -21.29B | -29.35B | -19.69B | -24.16B |
| Financing Cash Flow | -9.01B | -15.67B | -29.42B | 7.20B | -22.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | $10.03B | 23.32 | 30.64% | 0.32% | 5.12% | 16.01% | |
78 Outperform | $7.83B | 15.10 | 16.61% | 0.67% | 5.20% | -0.12% | |
74 Outperform | $14.79B | 53.05 | 11.51% | 0.18% | 21.37% | 173.02% | |
72 Outperform | $25.70B | 33.58 | 19.60% | 0.84% | 34.18% | -15.12% | |
70 Outperform | $82.64B | 135.06 | -13.63% | ― | 56.53% | -246.15% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $9.19B | 38.72 | 7.75% | 1.21% | 2.54% | -37.20% |